Cement News

Insee Cement presents EPO vaccines for kidney patients

Insee Cement presented over 10,000 doses of Erythropoietin (EPO) vaccines to the Ministry of Health to address the shortage of medicine due to the economic crisis.

The donation valued at Rs. 40 million, and procured and financed by Siam City Cement Public Limited, Insee Cement Sri Lanka’s parent company, was made by Insee Cement Sri Lanka in response to an urgent request by the Ministry of Health on the need to treat anaemia in patients suffering from Chronic Kidney Disease (CKD), a highly prevalent condition in rural areas of the country.

Director General of Health Services, Dr. Asela Gunawardena and Director, Medical Technology Services, Dr. Anver Hamdani,  Thailand Ambassador  Poj Harnpol and First Secretary, Peerapat Tongrod, Insee Cement Chairman Nandana Ekenayake and Head of External Affairs and Channel Development, Chandana Nanayakkara were present.

“As a responsible and exemplary corporate citizen, Insee Cement Sri Lanka continues to identify new avenues and initiatives that go beyond our scope of business, and support our fellow Sri Lankan citizens in this hour of need,” said Chairman and CEO of Insee Cement, Nandana Ekenayake.

“We appreciate the support of the Siam City Cement Public company, Thailand in procuring of the 10,000 vaccines, from Siam Bioscience Company of Thailand, and believe that our immediate and timely response to the urgent request made by the Ministry of Health serves to address the critical medicine shortage and help save lives,” he said.


Source link